Clincosm LogoSign in Get a demo

advanced breast cancer

Showing 1 - 25 of 143
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Breast Cancer Trial in Changsha (BEBT-209 capsules, Letrozole tablets, Fulvestrant)

Active, not recruiting
  • Advanced Breast Cancer
  • BEBT-209 capsules
  • +2 more
  • Changsha, Hunan, China
  • +1 more
Sep 14, 2023

Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

Not yet recruiting
  • Metastatic Breast Cancer
  • +4 more
  • CDK 4/6 inhibitors
  • Endocrine therapy
  • Helsinki, Finland
  • +11 more
Sep 19, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Everolimus 10 mg
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 14, 2023

Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)

Not yet recruiting
  • Advanced Breast Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Jun 28, 2023

Integrating Person-based Care in Treatment of Advanced

Recruiting
  • Advanced Breast Cancer
  • Sharing all key aspects associated with the quality of life in a single digital environment
  • Rome, Italy
    Fondazione Policlinico A. Gemelli - IRCCS
May 29, 2023

Advanced Breast Cancer Trial (XC, TPC)

Not yet recruiting
  • Advanced Breast Cancer
  • (no location specified)
May 16, 2023

Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy

Recruiting
  • Advanced Breast Cancer
  • The combination of Dalpiciclib with physician-selected endocrine therapy
  • Chemotherapy selected by the physician
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Advanced Breast Cancer Trial (Disitamab vedotin)

Not yet recruiting
  • Advanced Breast Cancer
  • Disitamab vedotin
  • (no location specified)
Apr 16, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (MEN1611, Eribulin)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • (no location specified)
Apr 12, 2023

Advanced Breast Cancer, Breast Tumor Malignant Female Trial in Guangzhou (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

Completed
  • Advanced Breast Cancer
  • Breast Neoplasm Malignant Female
  • AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Apr 11, 2023

Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

Recruiting
  • Advanced Breast Cancer
  • TQB3909 tablets
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Mar 16, 2023

PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

Not yet recruiting
  • PIK3CA Mutation
  • +7 more
  • (no location specified)
Mar 7, 2023

Advanced Breast Cancer Trial in Shijia Zhuang (SYHX2011, Paclitaxel for injection (albumin-bound))

Not yet recruiting
  • Advanced Breast Cancer
  • SYHX2011
  • Paclitaxel for injection (albumin-bound)
  • Shijia Zhuang, Hebei, China
    The Fourth Hospital of Hebei Medical University
Feb 22, 2023

Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

Not yet recruiting
  • Advanced Breast Cancer
  • +6 more
  • Providence, Rhode Island
    Lifespan Cancer Institute
Feb 1, 2023

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

Recruiting
  • Triple Negative Breast Cancer
  • +14 more
  • LYL797
  • Scottsdale, Arizona
  • +10 more
Jan 30, 2023

Advanced Breast Cancer Trial in Puerto Rico, United States (ARV-471, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Coconut Creek, Florida
  • +13 more
Jan 27, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (LY3484356, Abemaciclib, Everolimus)

Recruiting
  • Breast Cancer
  • +3 more
  • Gilbert, Arizona
  • +76 more
Jan 27, 2023

Advanced Breast Cancer Trial in Spain (Olaparib [Lynparza®] plus Trastuzumab [Herceptin®])

Terminated
  • Advanced Breast Cancer
  • Olaparib [Lynparza®] plus Trastuzumab [Herceptin®]
  • Barcelona, Spain
  • +16 more
Jan 18, 2023

Unraveling KAdcyla Resistance In Human Epidermal Growth Factor

Completed
  • Advanced Breast Cancer
    • Sevilla, Andalucía, Spain
    • +9 more
    Jan 12, 2023

    Advanced Breast Cancer Trial in Spain (Olaparib)

    Completed
    • Advanced Breast Cancer
    • Badalona, Barcelona, Spain
    • +15 more
    Jan 12, 2023

    Advanced Breast Cancer Trial in Spain (Pembrolizumab, Gemcitabine)

    Completed
    Has Results
    • Advanced Breast Cancer
    • Badalona, Barcelona, Spain
    • +8 more
    Apr 12, 2022

    Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)

    Recruiting
    • Breast Neoplasm
    • +4 more
    • PIK3CA inhibitor
    • +12 more
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jan 2, 2023

    Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)

    Withdrawn
    • Solid Tumor
    • Advanced Breast Cancer
    • Milwaukee, Wisconsin
      Froedtert Hospital and the Medical College of Wisconsin
    Dec 21, 2022

    Breast Cancer, Treatment Side Effects, Advanced Breast Cancer Trial in Shanghai (Tumor Infiltrating Lymphocytes (TIL))

    Recruiting
    • Breast Cancer
    • +3 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Shanghai, China
      Shanghai Tenth People's Hospital
    Dec 19, 2022